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Abstract. 
 
L-selectin, a lectin-like receptor, mediates 
rolling of lymphocytes on high endothelial venules 
(HEVs) in secondary lymphoid organs by interacting 
with HEV ligands. These ligands consist of a complex of 
sialomucins, candidates for which are glycosylation-
dependent cell adhesion molecule 1 (GlyCAM-1), 
CD34, and podocalyxin. The ligands must be sialylated, 
fucosylated, and sulfated for optimal recognition by
L-selectin. Our previous structural characterization of 
GlyCAM-1 has demonstrated two sulfation modiﬁca-
tions, Gal-6-sulfate and GlcNAc-6-sulfate in the con-
text of sialyl Lewis x. We now report the cloning of a 
Gal-6-sulfotransferase and a GlcNAc-6-sulfotrans-
ferase, which can modify GlyCAM-1 and CD34. The 
Gal-6-sulfotransferase shows a wide tissue distribution. 
In contrast, the GlcNAc-6-sulfotransferase is highly re-
stricted to HEVs, as revealed by Northern analysis and 
in situ hybridization. Expression of either enzyme in 
Chinese hamster ovary cells, along with CD34 and fuco-
syltransferase VII, results in ligand activity, as detected 
by binding of an L-selectin/IgM chimera. When coex-
pressed, the two sulfotransferases synergize to produce 
strongly enhanced chimera binding.
Key words: sulfotransferase • carbohydrate • L-selec-
tin • high endothelial venule • endothelium
 
S
 
ULFATION
 
 of carbohydrates attached to glycopro-
teins, glycolipids, and proteoglycans confers highly
specific functions onto these macromolecules (Nel-
son et al., 1995; Hooper et al., 1996; Rosenberg et al.,
1997). Examples of sulfation-dependent recognition phe-
nomena are seen in diverse biological systems, including
blood clotting, cytokine sequestration and receptor bind-
ing, control of the circulatory half-life of pituitary hor-
mones, and plant–bacterial symbiosis. Therefore, the sul-
fotransferases that catalyze the sulfation of carbohydrates
have become the focus of increasing research interest.
In recent years, the role of sulfated carbohydrates in
leukocyte–endothelial interactions has been established
(Kansas, 1996; Rosen and Bertozzi, 1996). During the pro-
cess of normal lymphocyte recirculation, L-selectin on
lymphocytes interacts with a set of sulfated glycoprotein
ligands on the endothelial cells of high endothelial venules
(HEVs).
 
1
 
 This interaction leads to lymphocyte rolling,
which constitutes the first step in the recruitment cascade
that culminates in the migration of the lymphocyte into
the underlying tissue (Springer, 1994; Butcher and Picker,
1996). The involvement of L-selectin in leukocyte recruit-
ment to certain sites of acute and chronic inflammation
has also been demonstrated (Lewinsohn et al., 1987; Ley
et al., 1991; Michie et al., 1993). The high endothelial cells
(HECs) of HEVs within lymphoid organs and of HEV-
like vessels that develop at sites of chronic inflammation
have long been known to incorporate large amounts of
[
 
35
 
S]sulfate in several species (Andrews et al., 1982; Girard
and Springer, 1995a). The functional significance of this
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N
 
-acetylglucosaminyltransferase; C6/KSST, chicken
chondroitin/keratan sulfate sulfotransferase; C6ST, human chondroitin-6-sul-
fotransferase; CM, conditioned medium; EST, expressed sequence tag; FTVII,
fucosyltransferase VII; Gal, galactose; GlcNAc, 
 
N
 
-acetylglucosamine; Gly-
CAM-1, glycosylation-dependent cell adhesion molecule 1; HEC, high endothe-
lial cell; HEC-GlcNAc6ST, HEC GlcNAc-6-sulfotransferase (AF131235,
AF131236); HEV, high endothelial venule; HPAEC, high pH anion exchange
chromatography; HUVEC, human umbilical vein endothelial cell; KSGal6ST,
keratan sulfate Gal-6-sulfotransferase; MFI, mean ﬂuorescence intensity; nt, nu-
 
cleotide(s); PE, phycoerythrin; RT, reverse transcriptase; sLe
 
x
 
, sialyl Lewis x
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extensive sulfation was not understood until the ligands
for L-selectin were elucidated.
To date, four discrete HEV-associated glycoprotein
ligands for L-selectin have been identified at the molecu-
lar level: glycosylation-dependent cell adhesion molecule 1
(GlyCAM-1) (Lasky et al., 1992), CD34 (Baumhueter et al.,
1993; Puri et al., 1995; Shailubhai et al., 1997), mucosal ad-
dressin cell adhesion molecule 1 (MAdCAM-1) (Berg et al.,
1993), and podocalyxin (Sassetti et al., 1998). At least one
other component, Sgp200, remains to be cloned (Berg et al.,
1991; Hemmerich et al., 1994b; Hoke et al., 1995). These
glycoproteins all contain mucin-like domains and are
heavily 
 
O
 
-glycosylated (Puri et al., 1995). It is well estab-
lished that optimal recognition of these ligands by the
C-type lectin domain of L-selectin requires sialylation (Imai
et al., 1991), fucosylation (Maly et al., 1996), and sulfation
(Imai et al., 1993). The protein scaffolds underlying these
ligands are also expressed in tissues other than HEVs,
such as mammary gland, non-HEV endothelium, hemato-
poietic precursors, and kidney podocytes (Dowbenko et al.,
1993; Baumhueter et al., 1994; Kershaw et al., 1997). How-
ever, the L-selectin–reactive glycoforms of these proteins
are highly restricted to HECs (Dowbenko et al., 1993;
Baumhueter et al., 1994; Sassetti et al., 1998).
To understand the posttranslational modifications that
underlie recognition of ligands by L-selectin, we previ-
ously undertook the analysis of the oligosaccharides of
GlyCAM-1 which was affinity purified with recombinant
L-selectin (Hemmerich and Rosen, 1994; Hemmerich et al.,
1994a, 1995). We detected two specific sulfated mono-
saccharides: 
 
N
 
-acetylglucosamine-6-sulfate (GlcNAc-6-sul-
fate) and galactose-6-sulfate (Gal-6-sulfate), which were
present in equal amounts. These sulfate modifications are
found, respectively, within two capping structures based
on sialyl Lewis x (sLe
 
x
 
): sialyl 6-sulfo Le
 
x
 
 and sialyl 6
 
9
 
-
sulfo Le
 
x
 
 (see Fig. 1 and Table I). The simplest chains of
GlyCAM-1 consist of sialyl 6
 
9
 
-sulfo Le
 
x
 
 and sialyl 6-sulfo
Le
 
x
 
 as extensions from an internal trisaccharide known as
core 2 (see Fig. 1 and Table I). More complex structures
with increased chain size and multiple sulfate esters com-
prise the majority of the chains and remain to be analyzed
in detail.
The sulfate dependence for L-selectin binding of HEV
ligands was first established in pharmacological experi-
ments with metabolic inhibitors of sulfation, i.e., chlorate
and brefeldin A (Imai et al., 1993; Hemmerich et al.,
1994b; Crommie et al., 1995; Shailubhai et al., 1997). Ad-
ditional evidence for the importance of sulfation has
emerged from studies with two mAbs, MECA-79 and G72.
MECA-79 stains lymph node HEVs and blocks L-selectin–
dependent lymphocyte attachment to HEVs in vitro and
in vivo (Streeter et al., 1988). This antibody also stains
HEV-like vessels that develop at sites of chronic inflam-
mation (Michie et al., 1993; Lee and Sarvetnick, 1994; Gi-
rard and Springer, 1995a; Onrust et al., 1996). MECA-79
reacts with all the L-selectin ligands described above (Imai
et al., 1991; Berg et al., 1993; Hemmerich et al., 1994b; Sas-
setti et al., 1998). This broad reactivity is thought to reflect
its binding to a posttranslational modification that is com-
mon to many L-selectin ligands (Berg et al., 1993; Hemmer-
ich et al., 1994b). The presence of the MECA-79 epitope is
currently accepted as a predictor of L-selectin ligand activ-
 
ity (Girard and Springer, 1995a). However, endothelial
and leukocyte ligands for L-selectin exist that lack this
epitope (Fuhlbrigge et al., 1996; Clark et al., 1998). Al-
though the precise structure of the MECA-79 epitope has
not been elucidated, it is critically dependent on sulfation
but does not require sialic acid or fucose (Hemmerich et
al., 1994b; Maly et al., 1996; Shailubhai et al., 1997). The
mAb G72 appears to have a more complex epitope in that
it reacts with synthetic sialyl 6-sulfo Le
 
x
 
 in a sialic acid–
and sulfate-dependent manner (Mitsuoka et al., 1998).
G72 stains HEVs in human peripheral lymph node in-
tensely and blocks the binding of a human L-selectin/IgG
chimera to HEV in vitro. Taken together, these results
strongly implicate sulfated structures, including sialyl 6-sulfo
Le
 
x
 
, as important recognition motifs for L-selectin binding
to HEVs.
The contribution of individual sulfate esters to L-selec-
tin binding affinity has been examined in several studies
using sulfated sLe
 
x
 
 structures or analogues thereof. Di-
rect binding measurements and competition studies have
yielded evidence for enhanced binding (compared with
sLe
 
x
 
) from the Gal-6-sulfate modification (Tsuboi et al.,
1996; Koenig et al., 1997), the GlcNAc-6-sulfate modifica-
tion (Scudder et al., 1994; Saunders et al., 1996; Galustian
et al., 1997), and from both (Yoshino et al., 1997). Signifi-
cantly, Bertozzi et al. (1995) found that several sulfated
variants of lactose were equal to or more potent than sLe
 
x
 
in inhibiting the binding of L-selectin to GlyCAM-1 in an
ELISA. For example, 6
 
9
 
,6-disulfo lactose (see Table I)
competed twofold better than sLe
 
x
 
, demonstrating that the
relevant sulfate modifications by themselves, in the ab-
sence of any contribution from sialic acid or fucose, can
confer a significant degree of binding to L-selectin.
In our search for the relevant sulfotransferases responsi-
ble for the synthesis of the specific sulfated carbohydrates
on L-selectin ligands, Bowman et al. (1998) recently iden-
tified a GlcNAc-6-sulfate sulfotransferase activity in por-
cine organs. This activity is highly expressed in lymph
node and spleen, relative to other tissues. Strikingly, it is
greatly enriched in HECs, with only scant activity detect-
able in lymph node lymphocytes or HEC-depleted stromal
cells. To identify candidate sulfotransferases at the molec-
ular level, we probed expressed sequence tag (EST) data-
bases for human sequences with homology to the cDNA
sequence for a chicken Gal-6-sulfotransferase (Fukuta et al.,
1995; Habuchi et al., 1996, 1997). Here, we describe the
cloning of two cDNAs encoding carbohydrate sulfotrans-
ferases that can modify GlyCAM-1 and CD34. One
enzyme is a Gal-6-sulfotransferase, which has been inde-
pendently cloned by another group. The other is a
novel  enzyme exhibiting GlcNAc-6-sulfotransferase activ-
ity. The Gal-6-sulfotransferase has a wide tissue distribu-
tion, whereas the GlcNAc-6-sulfotransferase is highly re-
stricted to HECs. Finally, we show that both enzymes can
contribute to the generation of functional ligands for
L-selectin and do so in a synergistic manner.
 
Materials and Methods
 
Semiquantitative Reverse Transcription PCR Analysis
 
HECs were purified from human tonsils as described previously (Sassetti 
Bistrup et al. 
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et al., 1998). Human umbilical vein endothelial cells (HUVECs) were pur-
chased from Clonetics. Total RNA was isolated from HECs, HUVECs,
and human tonsillar lymphocytes by lysis and extraction with RNAZol
(Tel-Test, Inc.). Approximately 45 
 
m
 
g RNA was obtained from 7 
 
3
 
 10
 
6
 
cells. First strand cDNA was made from 2 
 
m
 
g total RNA primed with ran-
dom hexamers using AMV reverse transcriptase (RT; Life Technologies,
Inc.). PCR reactions were carried out in a total volume of 10 
 
m
 
l of 1
 
3
 
KlenTaq buffer (Clontech) containing 400 nM primers, 200 
 
m
 
M dNTPs,
0.2 
 
m
 
l KlenTaq Advantage DNA polymerase mix (KlenTaq polymerase;
Clontech), and 1.0 
 
m
 
l of twofold serially diluted cDNA as template. Cy-
cling conditions were as follows: 1 min at 94
 
8
 
C; 30 cycles of 30 s at 92
 
8
 
C
followed by 1 min 15 s at 68
 
8
 
C; one cycle of 10 min at 68
 
8
 
C. The following
primers were used: for HEC-GlcNAc6ST, 5
 
9
 
-AAACTCAAGAAGGAG-
GACCAACCCTACTATGTGATGC-3
 
9
 
 and 5
 
9
 
-GTGGATTTGCTCA-
GGGACAGTCCAGCTAGACAGAAGAT-3
 
9
 
, which amplify a 456-bp
fragment corresponding to nucleotides (nt) 884–1339 in Fig 3 a; for hy-
poxanthine phosphoribosyltransferase (HPRT), 5’-CCTGCTGGATTA-
CATCAAAGCACTG-3
 
9
 
 and 5
 
9
 
-TCCAACACTTCGTGGGGTCCT-3
 
9
 
.
The resulting amplified DNA was electrophoresed and visualized by
ethidium bromide.
 
Preparation of an HEC cDNA Expression Library
 
A cDNA expression library was prepared from human HECs using the
SMART cDNA technology (Clontech), which incorporates a long-dis-
tance PCR amplification step of first strand cDNA. 1 
 
m
 
g of total HEC
RNA prepared as above was mixed with a modified oligo (dT) primer
(1 
 
m
 
M) containing a NotI site and a universal site for 3
 
9
 
 priming of the
PCR reaction and the SMART oligonucleotide (1 
 
m
 
M), which provides a
universal site for 5
 
9
 
 priming of the PCR reaction. This mixture was heated
at 72
 
8
 
C for 2 min to disrupt RNA secondary structure, and first strand
cDNA was synthesized by Moloney murine leukemia virus (MMLV) RT
in a total volume of 10 
 
m
 
l. 2 
 
m
 
l of this reaction mixture was subjected to 18
cycles of long-distance PCR primed by the universal primers using Klen-
Taq polymerase (Clontech). The PCR reaction mixture was incubated in
the presence of proteinase K for 1 h at 45
 
8
 
C to destroy the KlenTaq poly-
merase activity, followed by heat inactivation at 90
 
8
 
C for 10 min. The dou-
ble-stranded cDNA was polished by treatment with T4 DNA polymerase
at 16
 
8
 
C for 30 min, followed by ligation to EcoRI/BstXI adaptors (Invitro-
gen) overnight at 16
 
8
 
C in the presence of T4 DNA ligase. Adaptor-ligated
cDNAs were digested with NotI and then phosphorylated. The double-
stranded cDNA was purified by size fractionation, ligated into EcoRI/
NotI-digested pCDNA1.1 (Invitrogen), and introduced into 
 
Escherichia
coli
 
 MC1061/p3 (Invitrogen) by electroporation. The library contained
500,000 independent clones with an average insert size of 1.1 kb.
 
Molecular Cloning of HEC-GlcNAc6ST
 
HEC-GlcNAc6ST (human) was cloned from the HEC cDNA library by
modification of a pool selection procedure (Kolodkin et al., 1997). In
brief, an aliquot (comprising 400,000 colony forming units) of the ampli-
fied bacterial stock of the HEC cDNA library was plated onto 200 LB
plates and grown for 
 
z
 
18 h at 37
 
8
 
C. Each pool of 2,000 colonies was har-
vested and grown for an additional 2 h at 37
 
8
 
C, and glycerol stocks were
made. PCR analysis was performed, using the HEC-GlcNAc6ST–specific
primers described above, to identify positive pools. 1 of the 9 positive
pools was titered and plated onto 40 plates to yield 100 colonies per plate.
These pools were expanded and analyzed as in the first round. A single
positive subpool was titered and plated onto 20 plates of 10 colonies each.
Analysis of individual colonies by PCR resulted in a single positive clone,
which was sequenced (Sanger et al., 1977). To clone the murine HEC-
GlcNAc6ST, a 241-bp probe (nt 26–267) was amplified from the EST
clone (AA522184; Research Genetics Inc., Huntsville, AL) and used as
probe for screening a bacterial artificial chromosome (BAC) library from
the C57BL/6 mouse (Genome Systems, Inc.). From the single positive
clone, DNA was purified and sequenced directly, using primers derived
from EST AA522184 (forward: 5
 
9
 
-TGGGTCAGCATGCCTTCCATAC-
TAAC-3
 
9
 
; reverse: 5
 
9
 
-TTCTAAGATTCCGGTTGCTTCTCCGTGGAC-
3
 
9
 
) and then obtaining sequence upstream (1559 nt) and downstream (582
nt). The resulting 1926 nt sequence was confirmed by resequencing in
both directions.
 
Molecular Cloning of KSGal6ST
 
A human fetal brain library (
 
l
 
 ZAP; Stratagene) was the kind gift of Dr.
Marc Tessier-Lavigne at the University of California, San Francisco. Ap-
 
proximately 10
 
6
 
 plaques were screened with a probe consisting of a 730-bp
HindIII/BamHI restriction fragment from IMAGE Consortium clone
40604 (EMBL/GenBank/DDBJ accession no. R55609) using standard
techniques (Sambrook et al., 1989). 18 independent positive plaques were
identified after the second round of hybridization. Cloned fragments were
excised and sequenced as above.
 
Northern Blot Analysis
 
The probe for HEC-GlcNAc6ST consisted of a 496-bp fragment from
LifeSeq clone no. 2620445, corresponding to nt 1021–1516 of the cloned
cDNA (see Fig. 3 A). The probe was labeled with [
 
a
 
-
 
32
 
P]dATP (Amer-
sham Pharmacia Biotech) by the random decamer priming method (Strip-
EZ DNA kit; Ambion, Inc.). Multiple Tissue Northern blots (Clontech)
containing poly(A)
 
1
 
 RNA from various human tissues were hybridized at
60
 
8
 
C overnight in Rapid-Hyb (Amersham Pharmacia Biotech) and then
washed twice at room temperature for 15 min in 2
 
3
 
 SSC/0.1% SDS fol-
lowed by two 15-min washes at 60
 
8
 
C in 0.1
 
3
 
 SSC/0.1% SDS and autora-
diography. For the Northern blot to establish expression in HECs,
poly(A)
 
1
 
 RNA was prepared from 1.5 
 
3
 
 10
 
7
 
 HECs and 2.0 
 
3
 
 10
 
7
 
 HU-
VECs, respectively.
 
 
 
Isolation of the poly(A)
 
1
 
 RNA with oligo(dT) latex
beads was performed according to the manufacturer’s protocol (Oligotex
Direct kit; QIAGEN, Inc.). Approximately 2 
 
m
 
g poly(A)
 
1
 
 RNA was
loaded per lane. The RNA was separated by electrophoresis in a 1% de-
naturing agarose-formaldehyde gel and transferred to positively charged
nylon filters (Hybond N
 
1
 
). The filters were hybridized and washed as for
the Multiple Tissue blots. Blots were stripped using the Strip-EZ DNA kit
(Ambion, Inc.), according to the manufacturer’s protocol.
 
In Situ Hybridization
 
Paraffin sections (5 
 
m
 
M) from C57BL/6 mice were deparaffinized, fixed in
4% paraformaldehyde, and treated with proteinase K. After washing in
0.5
 
3
 
 SSC, the sections were covered with hybridization solution (50%
formamide, 300 mM NaCl, 20 mM Tris, pH 8.0, 5 mM EDTA, 1
 
3
 
 Den-
hardt’s, 10% dextran sulfate, 10 mM DTT), prehybridized for 1–3 h at
55
 
8
 
C, and hybridized overnight with sense or antisense 
 
35
 
S-labeled ribo-
probe transcribed from the IMAGE consortium clone 851801 (EMBL/
GenBank/DDBJ accession no. AA522184; Research Genetics, Inc.) which
had been modified by digestion with SacI followed by religation. After hy-
bridization, sections were washed at high stringency, dehydrated, dipped
in photographic emulsion NTB2 (Eastman Kodak Co.), stored at 4
 
8
 
C for
2–8 wk, developed, and counterstained with hematoxylin and eosin.
 
Sulfation of GlyCAM-1/IgG in COS Cells
 
For generation of recombinant GlyCAM-1/IgG fusion protein, COS-7
cells were grown to 80% confluency in a T162 culture flask (Corning-Cos-
tar) and transfected with 8 
 
m
 
g of a plasmid encoding GlyCAM-1/IgG and
8 
 
m
 
g of plasmid encoding either HEC-GlcNAc6ST (pCDNA1.1),
KSGal6ST (pCDNA3.1), or the empty vector (pCDNA1.1) using Lipo-
fectamine (Life Technologies) in Opti-MEM (Life Technologies). The
cDNA encoding the GlyCAM-1/IgG chimera was constructed by amplify-
ing the entire coding sequence of murine GlyCAM-1 (Lasky et al., 1992)
by PCR and cloning the resulting fragment into the pIG1 vector (Sim-
mons, 1993). Cells were grown for 12 h after transfection in DME con-
taining 10% FBS, then cell layers were washed once with PBS and cul-
tured for 72 h in serum-free medium (Endothelial SFM, 16 ml per flask;
GIBCO BRL) supplemented with Na
 
2
35
 
SO
 
4
 
 (0.25 mCi/ml, 1,400 Ci/
mmol; ICN). Recombinant GlyCAM-1/IgG fusion protein was isolated
from the conditioned medium (CM) by affinity chromatography on pro-
tein A–agarose (Watson et al., 1990). The protein was then transferred
into 50 mM ammonium bicarbonate on a Centricon 30 concentrator
(Amicon, Inc.). 1% of each sample was analyzed by SDS-PAGE, and the
remaining samples were lyophilized for subsequent acid hydrolysis and
positional analysis.
 
Analysis of Sulfated GlyCAM-1/IgG Carbohydrates
 
The lyophilized recombinant GlyCAM-1/IgG samples were hydrolyzed in
0.2 M H
 
2
 
SO
 
4
 
, and the hydrolysates were prepared for analysis by high pH
anion exchange chromatography (HPAEC) essentially as described previ-
ously (Hemmerich et al., 1994a), with the following modifications: (a) af-
ter 30 min hydrolysis in 0.2 M H
 
2
 
SO
 
4
 
 at 96
 
8
 
C, and before the initial gel fil-
tration step, excess sulfate was precipitated by addition of an equivalent
amount of Ba(AcO)
 
2
 
; (b) the second ion exchange column (DEAE- 
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Sepharose) was equilibrated in 2 mM pyridine-acetate, pH 5.0, and eluted
with a gradient of 2–500 mM pyridine-acetate. The monosulfated oligosac-
charides eluted from this column between 50 and 250 mM pyridine ace-
tate. The eluate was lyophilized, redissolved in 100 
 
m
 
l of water, and 30-
 
m
 
l
samples of the resulting solution were subjected directly to HPAEC.
HPAEC was performed using a Dionex DX 500 chromatographic analysis
system and a Carbopac 1 column (Dionex Corp.) essentially as described
(Hemmerich et al., 1994a, 1995), with column elution performed isocracti-
cally with 150 mM NaOH in 400 mM NaOAc at 1 ml/min. The authentic
carbohydrate standards used in this analysis were obtained as described
(Hemmerich et al., 1994a, 1995).
 
Flow Cytometry
 
CHO/FTVII/C2GnT cells were grown to 80% confluency in T75 flasks
(6 
 
3
 
 10
 
6
 
 cells per flask; Nalge Nunc) and then transfected with plasmids
encoding C2GnT (1 
 
m
 
g, pCDNA1.1), fucosyltransferase VII (FTVII; 1 
 
m
 
g,
pCDNA3.1), human CD34 (2 
 
m
 
g, pRK5), sulfotransferases (at the
concentrations indicated for each experiment), and vector plasmid
(pCDNA3.1) to achieve 8 
 
m
 
g total DNA per flask, using Lipofectamine.
48 h after transfection, the cells were harvested in 0.6 mM EDTA in PBS
without calcium and magnesium, washed once in assay buffer (0.1% BSA
in PBS), and resuspended at 4 
 
3
 
 10
 
6
 
/ml in assay buffer. 25 
 
m
 
l of this cell
suspension was added to wells of 96-well plates containing 50 
 
m
 
l of
L-selectin/IgM chimera, or assay buffer. Cells were incubated on ice for
30 min, washed twice in assay buffer, and resuspended in 50 
 
m
 
l assay
buffer containing secondary staining reagents. Cells were incubated for
another 30 min, washed twice in assay buffer, and then resuspended in
50 
 
m
 
l assay buffer containing tertiary staining reagents and/or directly con-
jugated primary mAbs. For the sialyl 6-sulfo Le
 
x
 
 or overall sLe
 
x
 
 determi-
nations, cells were incubated with G72 mAb or HECA 452 (PharMingen),
respectively, diluted in assay buffer, and then reacted with rabbit anti–
mouse IgG-FITC (Zymed Laboratories, Inc.) (for G72) or mouse anti–rat
IgM-FITC (PharMingen) (for HECA 452). The cells were incubated for
30 min, washed twice, and fixed in 1.5% paraformaldehyde in PBS, pH 7,
for 20 min before transfer into 300 
 
m
 
l of assay buffer. Cells were analyzed
on a FACSort™ (Becton Dickinson) flow cytometer using CELLQuest
software (Becton Dickinson). To produce the L-selectin/IgM chimera
(Maly et al., 1996), COS cells (10-cm plates) were transfected with
L-selectin/IgM cDNA in pCDM8 (8 
 
mg cDNA, 50 ml Lipofectamine per
plate) and incubated in Opti-MEM for 10 d, at which time the CM was
harvested and clarified by centrifugation. The CM was concentrated to
half its original volume, titered, and used neat. Biotinylated goat anti–
human IgM (m) and streptavidin-FITC were purchased from Caltag Labo-
ratories. The L-selectin mAb Mel-14 (Gallatin et al., 1983) was purified by
ammonium sulfate precipitation from hybridoma cell culture supernatant,
followed by immunoaffinity purification with mouse L-selectin/IgG. The
control for Mel-14 was a rat IgG2a myeloma (Zymed Laboratories, Inc.).
For the two-color analysis, we used mouse anti-CD34 phycoerythrin (PE)
(QBend10-PE; Coulter Corp.) and the isotype-matched control, mouse
IgG1-PE (Caltag Laboratories).
Results
Identification of Two cDNAs Predicting
Carbohydrate Sulfotransferases
Our previous structural analysis of the carbohydrate
chains of GlyCAM-1 indicated that the Gal-6-sulfate and
GlcNAc-6-sulfate modifications accounted for essentially
all of the sulfation of GlyCAM-1 (Hemmerich et al.,
1994a). The previously cloned chicken chondroitin/kera-
tan sulfate sulfotransferase (C6/KSST) has been shown by
Habuchi et al. (1997) to catalyze sulfation at C-6 of galac-
tose in Siaa2®3Galb1®4GlcNAc, which is a core struc-
ture within the capping groups shown in Fig. 1. We used
the cDNA sequence encoding C6/KSST to probe the Na-
tional Center for Biotechnology Information (NCBI)
dbEST and LifeSeq (Incyte Pharmaceuticals, Inc.) human
EST databases for related sequences. When we examined
expression of transcripts corresponding to the ESTs by
Northern analysis, one (corresponding to LifeSeq clone
no. 2620445, derived from a human breast epithelial cell
line) was of particular interest, because its tissue distribu-
tion was highly restricted (original finding not shown, but
result demonstrated in Fig. 2 B). To determine whether
this gene was expressed in HECs, a cell type in which L-selec-
tin ligands are elaborated, we carried out a semiquantita-
tive RT-PCR analysis on HEC cDNA with primers de-
rived from this EST. HECs were purified, as described
previously, from human tonsils using immunomagnetic
separation with MECA-79 as the probe (Girard and
Springer, 1995b; Sassetti et al., 1998). The resulting cells
had a purity of .99% and represented ,1 per 1,000 of the
stromal cells in tonsils. In parallel, we prepared cDNA
from HUVECs and tonsillar lymphocytes. As shown in
Fig. 2 A, the primers specific for the novel gene amplified
a fragment of 456 bp from HEC cDNA, but failed to am-
plify this product from the HUVEC or lymphocyte cDNA.
Since we had a relatively small number of HECs avail-
able, we used a PCR-based technique (SMART technol-
ogy; Clontech, Inc.) to produce cDNA from total RNA,
from which we prepared a plasmid expression library. Us-
ing PCR amplification of the 456-bp fragment to identify
positive pools, we isolated a full-length cDNA clone from
the library by a pool selection procedure, as described in
Materials and Methods. Initially, 200 pools of 2,000 col-
ony-forming units/pool were screened. After two addi-
tional rounds of screening, a single positive clone was ob-
tained. The cDNA corresponding to this clone contains a
single open reading frame of 1,158 nucleotides. The cDNA
is apparently full-length as indicated by the presence of an
upstream stop codon and a Kozak sequence surrounding
the first ATG, and a poly(A) tail at the 39 end. This open
reading frame predicts a type II transmembrane protein of
386 amino acids with 3 potential sites for N-linked glycosy-
Figure 1. Sulfated O-linked carbohydrate chains of GlyCAM-1.
Oligosaccharides bearing the 6-sulfo sLex and the sialyl 69-sulfo
Lex motif, which extend from the core 2 structure, are shown.
The presence of the sialyl 69,6-disulfo Lex motif is strongly sus-
pected. Structures of the more complex O-linked chains of Gly-
CAM-1 remain to be determined.Bistrup et al. Sulfotransferases and L-selectin Ligands 903
lation. The new cDNA sequence was used to probe the hu-
man databases for additional matching ESTs. One EST
was identified in the LifeSeq database that mapped to the
new gene at the 59 end of its protein coding region. When
the clone (no. 2617407, derived from gall bladder) corre-
sponding to this EST was fully sequenced, its sequence
completely matched the original cDNA sequence within
the coding region. There were two base changes in the 39
untranslated region and divergence in the 59 untranslated
region. We present the sequence corresponding to LifeSeq
clone no. 2617407 (Fig. 3 A; EMBL/Genbank/DDBJ ac-
cession no. AF131235), since the library from which it was
cloned was created without a PCR amplification step. The
predicted amino acid sequence of this novel gene is 31%
identical to C6/KSST (Fukuta et al., 1995), the chicken
enzyme used in the original EST search. We have termed
this novel gene HEC-specific GlcNAc-6-sulfotransferase
(HEC-GlcNAc6ST) on the basis of the characterization
described below.
Using the human HEC-GlcNAc6ST cDNA sequence as
a probe, we identified a highly related mouse sequence in
the NCBI dbEST database (EMBL/GenBank/DDBJ ac-
cession no. AA522184). A 241-bp probe based on this EST
was used for screening of a BAC library from mouse
(C57BL/6). The probe was found to hybridize to a single
BAC. The genomic clone within this BAC contained an
open reading frame of 1167 bp (EMBL/Genbank/DDBJ
accession no. AF131236), which is 77% identical at the nt
level to the coding region of the human HEC-GlcNAc6ST.
No introns were detected. The sequence predicts a protein
of 388 amino acids (Fig. 3 A), which is 73% identical to
that of human HEC-GlcNAc6ST. We term this apparent
mouse homologue mHEC-GlcNAc6ST.
The expression of HEC-GlcNAc6ST was confirmed to
be highly restricted by further analysis. On a conventional
Northern blot (human), transcripts corresponding to this
gene were absent from most tissues (Fig. 2 B). Low levels
of a 2.4-kb transcript were apparent in lymph node, liver
(adult and fetal), and pancreas. A prominent band of the
same size was detected at relatively high levels in mRNA
from HECs, but was undetectable in HUVEC mRNA
(Fig. 2 B). An additional transcript at z6 kb was expressed
in liver and pancreas, and trace levels appeared to be
present in lymph node, HECs, and HUVECs (Fig. 2 B).
Using an antisense riboprobe based on the original mouse
EST, we carried out in situ hybridization on mouse tissues.
Strikingly, mHEC-GlcNAc6ST transcripts were detected
only in the HEVs of lymph node (Fig. 4). No hybridizing
signal was found in other cell types of the lymph node, or
in several other organs, including spleen, thymus, liver,
skeletal muscle, pancreas, stomach, and kidney (data not
shown). A weak signal was detected in gut intestinal epi-
thelium (data not shown). The sense control did not yield
signal in any tissue.
Our screening of the human EST databases with the
chicken C6/KSST led to the identification of multiple
ESTs that mapped to another gene. We cloned a cDNA
for this gene by conventional techniques from a fetal brain
library as described in Materials and Methods. While this
work was in progress, the same cDNA (with only two base
changes in untranslated regions) was published indepen-
dently by Fukuta et al. (1997). The expressed protein was
characterized as a keratan sulfate sulfotransferase with
Gal-6-sulfotransferase activity (KSGal6ST) (Fukuta et al.,
1997). The predicted protein is a type II transmembrane
protein of 411 amino acids with 32% identity to HEC-
GlcNAc6ST. Fukuta et al. (1997) reported the expression
of KSGal6ST in many tissues, including lymph node. We
confirmed these results; in addition, we detected its ex-
pression in HECs, albeit at apparently low levels, by per-
Figure 2. Expression of
HEC-GlcNAc6ST tran-
scripts in HECs. (A)
Semiquantitative RT-PCR
analysis. Fragments of
the HEC-GlcNAc6ST and
HPRT sequences were am-
plified by PCR from serial
dilutions of cDNA pre-
pared from purified HECs,
HUVECs, and tonsillar
lymphocytes. The reaction
products (456 and 300 bp,
respectively) were ana-
lyzed by agarose electro-
phoresis and ethidium bro-
mide staining. 2RT, PCR
reactions in which the tem-
plate was generated by
omission of RT. (B) North-
ern blotting. Northern blots
containing poly(A)1 RNA
from various human tissues
(left and center) and from
HECs and HUVECs (right) were probed with a 500-bp fragment from the HEC-GlcNAc6ST cDNA (top panels). The blots were
stripped and reprobed with a 300-bp probe for b-actin (bottom panels).The Journal of Cell Biology, Volume 145, 1999 904
forming RT-PCR with HEC cDNA and the HEC-cDNA
library (data not shown).
Sulfation of GlyCAM-1 by KSGal6ST
and HEC-GlcNAc6ST
To test whether KSGal6ST and HEC-GlcNAc6ST (hu-
man) were capable of sulfating an L-selectin ligand, we
transfected COS cells with a cDNA encoding a GlyCAM-
1/IgG chimera and a cDNA encoding one or the other sul-
fotransferase. The transfected cells were cultured in the
presence of [35S]sulfate, and radiolabeled GlyCAM-1/IgG
was purified from the CM on protein A–agarose. As
shown in Fig. 5 A, there was substantial incorporation of
radioactivity into GlyCAM-1/IgG when either KSGal6ST
or HEC-GlcNAc6ST cDNA (but not empty vector) was
included in the cotransfection.
To establish the regiochemistry of sulfation on radiola-
beled GlyCAM-1/IgG, samples resulting from the two sul-
fotransferase transfections were subjected to hydrolysis
and Dionex HPLC analysis according to our previously es-
tablished procedures (Hemmerich et al., 1994a). As shown
in Fig. 5 B, transfection with KSGal6ST resulted in sul-
fated mono- and disaccharides that comigrated with
[SO3®6]Gal and [SO3®6]Galb1®4GlcNAc, confirming
this enzyme as a Gal-6-sulfotransferase (Fukuta et al.
1997). In contrast, transfection with HEC-GlcNAc6ST re-
sulted in products that corresponded to [SO3®6]GlcNAc
and Galb1®4[SO3®6]GlcNAc. Thus, this enzyme was es-
tablished to be a novel GlcNAc-6-sulfotransferase.
Generation of Sialyl 6-sulfo Lex with HEC-GlcNAc6ST
To determine whether the HEC-GlcNAc6ST could con-
tribute to the generation of sialyl 6-sulfo Lex (Table I), we
took advantage of the G72 mAb, which recognizes this
structure in a sulfate-dependent manner (Mitsuoka et al.,
1998). We carried out transfection experiments with CHO
cells, termed CHO/FTVII/C2GnT, which had been stably
transfected with (a) fucosyltransferase VII (FTVII) to
provide a1®3 Fuc, and (b) core 2 b1®6  N-acetylglu-
cosaminyltransferase (C2GnT) (Bierhuizen and Fukuda,
1992) to provide a core structure for O-linked glycans (Fig.
1) upon which extended chains with sLex capping groups
can be elaborated (Li et al., 1996). The modified CHO
cells were transiently transfected with HEC-GlcNAc6ST
or KSGal6ST cDNA as a control. Transfection of the
CHO cells with HEC-GlcNAc6ST cDNA resulted in sig-
nificant staining by G72 as measured by flow cytometry
(Fig. 6), whereas transfection with KSGal6ST did not yield
staining (not shown). Similar results were obtained with
G152 (Mitsuoka et al., 1998), a related mAb (data not
shown). Inclusion of a CD34 cDNA in the transfection did
not significantly enhance staining by G72, indicating that
an exogenous mucin scaffold was not required for the ex-
pression of this epitope.
Contribution of KSGal6ST and HEC-GlcNAc6ST to 
the Generation of L-selectin Ligand Activity
Since HEC-GlcNAc6ST and KSGal6ST are both expressed
Figure 3. Molecular features
of human and mouse HEC-
GlcNAc6ST. (A) cDNA se-
quence for human HEC-
GlcNAc6ST and predicted
protein sequences of human
(h) and mouse (m) HEC-
GlcNAc6STs (EMBL/Gen-
Bank/DDBJ accession nos.
AF131325 and AF131236, re-
spectively). The open read-
ing frame is denoted by capi-
tal letters, and the predicted amino acid sequences are indicated
below the nucleotide sequence. The putative transmembrane do-
mains are underlined, and three potential N-linked glycosylation
sites (for each sequence) are indicated by asterisks. (B) Align-
ment of regions of high conservation among human carbohydrate
6-sulfotransferases (Gal-6, GlcNAc-6, and GalNAc-6). Protein
sequences were aligned using the ClustalW algorithm (Thomp-
son et al., 1994). Black shading indicates identity at that residue
among at least three of the sequences; grey shading indicates sim-
ilarity among the shaded residues.
Table I. Nomenclature and Structure of Oligosaccharides
Name Structure
sLex Siaa2®3Galb1®4[Fuca1®3]GlcNAc
Sialyl 69-sulfo Lex Siaa2®3[SO3®6]Galb1®4[Fuca1®3]GlcNAc
Sialyl 6-sulfo Lex Siaa2®3Galb1®4[Fuca1®3][SO3®6]GlcNAc
Sialyl 69,6-disulfo Lex Siaa2®3[SO3®6]Galb1®4[Fuca1®3]
[SO3®6]GlcNAc
Core 2 Galb1®3[GlcNAcb1®6]GalNAc
69,6-disulfo lactose [SO3®6]Galb1®4[SO3®6]GlcBistrup et al. Sulfotransferases and L-selectin Ligands 905
in HECs and are capable of sulfating GlyCAM-1/IgG in
transfected cells, they are candidates to participate in the
biosynthesis of L-selectin ligands. Our previous structural
analysis indicated that Gal-6-sulfate and GlcNAc-6-sulfate
are present equally in native GlyCAM-1 oligosaccharides.
However, as reviewed above, the relative contribution of
the two sulfate esters to L-selectin binding affinity has
been a matter of considerable uncertainty. To test whether
these enzymes can contribute to the generation of ligand
activity, we carried out further flow cytometry experi-
ments with an L-selectin/IgM chimera as a probe. The
CHO/FTVII/C2GnT cells were transiently transfected with
cDNAs for the two sulfotransferases (singly or in combi-
nation) plus a CD34 cDNA. As shown in Fig. 7 A, no
binding of the chimera was detected in the absence of the
sulfotransferases. Transfection with either sulfotransferase
yielded positive staining, both in terms of the proportion
of positive cells and their mean fluorescence intensity
(MFI). Strikingly, the combination of KSGal6ST and
HEC-GlcNAc6ST cDNAs produced strongly enhanced
binding of L-selectin/IgM, which greatly exceeded the sum
of the signals from the individual sulfotransferases (Fig. 7
A). This apparent synergistic effect was evident over a
considerable range of cDNA concentrations in the trans-
fection mixtures (Tables II and III). The binding of the
L-selectin/IgM chimera induced by the sulfotransferases was
confirmed to be specific as indicated by its calcium depen-
dence (data not shown) and complete inhibition binding
by a function-blocking anti–L-selectin mAb (MEL-14; Fig.
7 B). The effects of the sulfotransferases on the L-selectin/
IgM chimera were not due to differences in transfection
efficiency, as the CD34 expression levels were essentially
constant, irrespective of the combinations of sulfotrans-
ferase cDNAs in the transfection mixtures (Table II). Fur-
Figure 4. In situ hybridization to detect HEC-GlcNAc6ST transcripts in mouse lymph node. Sections of C56BL/6 mouse lymph node
were hybridized with 35S-labeled sense or antisense riboprobes based on the clone corresponding to the mouse homologue of HEC-
GlcNAc6ST. Dark field micrographs of the sections are shown. Signal is seen as bright dots. (A) Hybridization with antisense probe,
whole lymph node shown. The only source of signal are HEVs, seen as distinctive high-walled vessels in the cortex of the node. (B) Hy-
bridization with sense probe of section adjacent to that in A. (C) Higher magnification view of area indicated by arrow in A. Two large
HEVs are evident.
Figure 5. Sulfation of Gly-
CAM-1/IgG by sulfotrans-
ferases. COS cells were
transfected with combina-
tions of plasmids encoding
GlyCAM-1/IgG, KSGal6ST,
and HEC-GlcNAc6ST, as in-
dicated. Transfected cells
were cultured in the presence
of [35S]sulfate, and recombi-
nant GlyCAM-1/IgG was
isolated from the CM. 1% of
the captured material was
analyzed by SDS-PAGE,
and the remainder was sub-
jected to hydrolysis and com-
positional analysis. (A) Au-
toradiograph (top) and
Coomassie Blue staining
(bottom) of SDS gel. Densi-
tometric quantification of
the Coomassie Blue–stained
bands showed that each lane, except the control lane without GlyCAM-1/IgG plasmid, contained approximately equal amounts of Gly-
CAM-1/IgG. (B) Sulfated carbohydrates produced in GlyCAM-1 by transfection with HEC-GlcNAc6ST (n) or KSGal6ST (d) were
analyzed by Dionex chromatography after acid hydrolysis. The following standards are indicated: 1, GlcNAc-3SO3
2; 2, [35S]SO4
22; 3,
Galb1®4[SO3
–®6]GlcNAc; 4, [SO3
–®6]Galb1®4GlcNAc; 5, Gal-4SO3
–; 6, Gal-3SO3
–; 7, GlcNAc-6SO3
–; 8, Gal-6SO3
–.The Journal of Cell Biology, Volume 145, 1999 906
thermore, to control for the possibility that the sulfotrans-
ferases might cause changes in essential glycosylation
parameters that could affect L-selectin binding, we stained
the transfected cells with the HECA 452 mAb. This anti-
body recognizes sLex-related structures and is widely used
as a reporter for glycosylation modifications (sialylation
and fucosylation) pertinent to selectin ligands (Wagers et
al., 1997; Tu et al., 1999). Because this antibody reacts
equally well with sulfated (at Gal-6, GlcNAc-6, or both)
and nonsulfated sLex structures (Mitsuoka et al., 1998), it
was of particular utility for detecting the overall presence
of sLex on the cell surface of the transfectants. As shown
in Table III, the expression of the HECA 452 epitope was
not significantly altered (,25% variation) by transfection
with the sulfotransferase cDNAs in any combination. The
final issue we investigated was the contribution of CD34 to
the expression of L-selectin ligand activity. In striking con-
trast to the results with G72, the binding of L-selectin/IgM
was dependent on the presence of the CD34 protein scaf-
fold, as there was a nearly complete loss of staining when
the CD34 cDNA was omitted from the transfection (Fig. 7
C). Interestingly, among the CD34-positive population,
only those cells expressing the highest levels stained with
the L-selectin/IgM chimera (Fig. 7 A).
Discussion
Sulfation plays a central role in the interactions of L-selec-
tin and P-selectin with their physiological ligands (Rosen
Figure 6. Generation of sia-
lyl 6-sulfo Lex by transfec-
tion with HEC-GlcNAc6ST
cDNA. CHO/FTVII/C2GnT
cells were transfected with a
cDNA encoding HEC-
GlcNAc6ST, with or without
CD34 cDNA. Cells were
stained with the G72 mAb to
detect the presence of sialyl
6-sulfo Lex. Histogram shows G72 staining for the transfections
with (red) or without (blue) CD34 cDNA, or staining of the iso-
type control antibody for the transfection with CD34 cDNA
(black).
Table II. L-selectin/IgM and CD34 Staining of CHO Cells 
Transfected with Combinations of Sulfotransferase cDNAs
cDNA transfected MFI
KSGal6ST HEC-GlcNAc6ST L-sel/IgM staining CD34 staining
mg
0 0 0 660
1.0 0 364 742
1.5 0 391 731
0 1.0 114 748
0 1.5 163 700
0.5 0.5 935 743
1.0 0.5 917 684
0.5 1.0 830 703
CHO/FTVII/C2GnT cells were cotransfected with plasmids encoding CD34 (2 mg)
and each sulfotransferase singly or in combination in the indicated amounts. Data are
expressed as the mean fluorescence intensity (MFI) of L-selectin/IgM staining in the
L-sel–IgM1/CD341 population with background signal (from transfectants with
CD34 cDNA alone, value 139) subtracted. Also shown is the MFI for staining with a
CD34 mAb (Qbend-10) for the population that was positive for CD34, as defined by
staining with the class-matched control antibody.
Figure 7. L-selectin reactivity conferred to CD34 by transfection
with HEC-GlcNAc6ST and KSGal6ST cDNAs. CHO/FTVII/
C2GnT cells were transfected with different combinations
of cDNAs encoding human CD34, HEC-GlcNAc6ST, and
KSGal6ST. Cells were stained with the L-selectin/IgM chimera to
detect ligand activity. (A) Two-color analysis showing CD34 ex-
pression (y-axis, staining with CD34-PE mAb) and L-selectin
ligand activity (x-axis, FITC) in cells transfected with CD34
cDNA and cDNAs encoding HEC-GlcNAc6ST and KSGal6ST,
alone or in combination as indicated. The horizontal bar is set
such that all cells staining with the isotype-matched control for
the CD34 mAb are included in the lower quadrants. The vertical
bar is set to indicate the L-selectin/IgM staining of cells in which
no sulfotransferase cDNA was included in the transfection mix-
ture (bottom left panel). The fraction of positive cells (as a per-
centage of the total) in each quadrant is indicated. The mean flu-
orescence intensity (MFI) for the cells in the top right quadrants
is indicated. The CD34 mAb did not interfere with staining by the
L-selectin/IgM chimera. (B and C) Histograms showing L-selec-
tin/IgM staining for the following transfections: CD34 cDNA
only (blue, B and C); CD34/HEC-GlcNAc6ST/KSGal6ST cDNAs
(red, B and C); CD34/HEC-GlcNAc6ST/KSGal6ST cDNAs with
staining done in the presence of Mel-14 mAb (green, B); HEC-
GlcNAc6/KSGal6ST cDNAs but no CD34 cDNA (green, C).
The secondary staining reagent when used alone showed staining
equal to that observed when Mel-14 mAb was used as an inhibi-
tor. The isotype-matched control for Mel-14 showed no inhibi-
tory effect.Bistrup et al. Sulfotransferases and L-selectin Ligands 907
and Bertozzi, 1996). PSGL-1, a leukocyte ligand for both
P-selectin and L-selectin (McEver and Cummings, 1997),
possesses a cluster of sulfated tyrosine residues, which fa-
cilitate binding of both selectins (Pouyani and Seed, 1995;
Sako et al., 1995; Wilkins et al., 1995; Snapp et al., 1998).
As reviewed above, L-selectin recognition of its cognate
HEV ligands requires sulfation, as well as fucosylation and
sialylation, for optimal binding. For the molecularly de-
fined HEV ligands, sulfation is on sugar moieties rather
than tyrosine residues (Rosen and Bertozzi, 1996). Our
objective has been the molecular identification of the sul-
fotransferases that participate in the biosynthesis of these
endothelial ligands. The specificities of the desired sul-
fotransferases were dictated by the analysis of the oli-
gosaccharides of L-selectin–reactive GlyCAM-1, which re-
vealed the presence of Gal-6-sulfate and GlcNAc-6-sulfate
in the context of sLex (sialyl 69-sulfo Lex and sialyl 6-sulfo
Lex, respectively). Similarly, the functional glycoforms of
CD34 also contain Gal-6-sulfate and GlcNAc-6-sulfate
in approximately equal representations (Hemmerich and
Rosen, unpublished observations). Histochemical evi-
dence with carbohydrate-directed mAbs shows that sialyl
6-sulfo Lex is prominently displayed on the HEVs of hu-
man peripheral lymph node (Mitsuoka et al., 1998), fur-
ther implicating a GlcNAc-6-sulfotransferase activity in
the biosynthesis of L-selectin ligands. Bowman et al.
(1998) recently characterized such an activity from porcine
lymph node, which was highly enriched in HECs.
To identify the relevant sulfotransferases at the molecular
level, we probed human EST databases for homologues of
the chicken C6/KSST, a bona fide Gal-6-sulfotransferase.
Here we report the cloning of two carbohydrate sulfo-
transferases. One is indeed a Gal-6-sulfotransferase, which
was independently discovered by Fukuta et al. (1997) and
named KSGal6ST. The second enzyme, which we have
termed HEC-GlcNAc6ST, is a novel GlcNAc-6-sulfo-
transferase. These two sulfotransferases, together with the
chicken C6/KSST (Fukuta et al., 1995), and the recently
reported human chondroitin-6-sulfotransferase (C6ST,
specificity for C-6 of GalNAc) (Fukuta et al., 1998) and
GlcNAc-6-sulfotransferase (GlcNAc6ST) (Uchimura et
al., 1998a,b) constitute a family of highly conserved en-
zymes. Overall, amino acid identities within the family
range from 27 to 42%. These enzymes are type II trans-
membrane proteins with short cytoplasmic tails, features
that are typical of glycosyltransferases and carbohydrate
sulfotransferases.
Within this new family of carbohydrate sulfotrans-
ferases, there are three regions of amino acid sequence in
which amino acid identity ranges from 45 to 54% and sim-
ilarity from 80 to 90% (Fig. 3 C). Regions one and two
contain elements that conform to the recently described
consensus binding motifs for the high energy sulfate do-
nor, 39-phosphoadenosine 59-phosphosulfate. These ele-
ments are found in all sulfotransferases characterized to
date (Kakuta et al., 1998). In addition, regions one and
three contain two stretches of sequence of 11 amino acids
each (corresponding to amino acids 124–134 and 328–339,
respectively, in the HEC-GlcNAc6ST sequence) that are
highly conserved (.90% similarity). It is possible that
these two elements contribute to a binding pocket that in-
teracts with the 6-hydroxyl group of an appropriate oli-
gosaccharide acceptor (Gal, GalNAc, or GlcNAc) to bring
it into apposition with the donor phosphosulfate group.
Our characterization of the KSGal6ST and HEC-
GlcNAc6ST supports their involvement in the synthesis of
L-selectin ligands. KSGal6ST has a wide tissue distribu-
tion which includes HECs. HEC-GlcNAc6ST shows a
highly restricted, although not absolute, localization to
HECs. Second, the sulfotransferases catalyze the two spe-
cific sulfation modifications on a recombinant L-selectin
ligand that have been established to occur on native
ligands. In the case of HEC-GlcNAc6ST, we have used the
G72 mAb to show that transfection with the cDNA leads
to 6-sulfation of sLex on the cell surface of CHO/FTVII/
C2GnT cells. This finding establishes that recombinant
HEC-GlcNAc6ST can be used to generate a highly spe-
cific sulfated structure that is present on lymph node
HEVs (Mitsuoka et al., 1998).
Using a flow cytometry assay based on the binding of an
L-selectin/IgM chimera to transfected CHO/FTVII/C2GnT
cells, we showed that each enzyme imparts L-selectin
binding. Control experiments established that the effects
of the sulfotransferases were not due to indirect effects on
transfection efficiencies or to global changes in glycosyla-
tion parameters of the cells. In contrast to the generation
of the G72 epitope, L-selectin/IgM binding required cotrans-
fection of the cells with a CD34 cDNA. These results indi-
cate that a specific protein scaffold, not present endoge-
nously in CHO cells, is needed for optimal ligand activity,
although at least one of the relevant sulfated carbohydrate
epitopes (sialyl 6-sulfo Lex) can be formed without the
provision of such a scaffold. This finding is analogous to
the situation with P-selectin, in which sLex determinants
can be formed by transfection of COS cells with an appro-
priate fucosyltransferase cDNA, but ligand activity re-
quires the inclusion of PSGL-1 cDNA (Sako et al., 1993).
As noted above, a shared feature of the molecularly de-
fined HEV-associated ligands for L-selectin is the pres-
ence of a mucin region (Puri et al., 1995). This feature
provides the potential for multivalent presentation of car-
bohydrate recognition determinants, which is thought to
be important for enhancing the avidity of L-selectin inter-
actions (Nicholson et al., 1998). Thus, the CD34 contribu-
tion to ligand activity seen in the present study may be pri-
marily due to its mucin character. The ability of other
Table III. L-selectin/IgM and HECA 452 Staining of CHO 
Cells Transfected with Combinations of
Sulfotransferase cDNAs
cDNA transfected MFI
KSGal6ST HEC-GlcNAc6ST L-sel/IgM staining HECA staining
mg
0 0 0 665
1.0 0 197 697
0 1.0 60 496
0.5 0.5 836 561
CHO/FTVII/C2GnT cells were cotransfected with plasmids encoding CD34 (2 mg)
and each sulfotransferase singly or in combination in the indicated amounts. Data are
expressed as the MFI of L-selectin/IgM staining in the L-sel–IgM1/CD341 population
with background signal (from transfectants with CD34 cDNA alone, value 182) sub-
tracted. Also shown is the MFI for staining with the HECA 452 mAb for the entire
population. The MFI for staining with a control antibody was ,10.The Journal of Cell Biology, Volume 145, 1999 908
mucins to perform this postulated scaffold function and
their possible distinct usage of the different sulfotrans-
ferases are questions for future investigation.
While each sulfotransferase was capable of conferring
L-selectin binding onto CD34 in the CHO/FTVII/C2GnT
cells, the greatest effect was clearly produced by the com-
bined action of the two sulfotransferases. The level of
binding achieved in the cells transfected with both sul-
fotransferases could not be attained with either sulfotrans-
ferase alone, over a wide range of cDNA concentrations.
These findings argue that optimal binding to L-selectin re-
quires both the Gal-6-sulfate and GlcNAc-6-sulfate moi-
eties. It is possible that this synergy arises through dual
recognition of separate monosulfated chains, for example
one chain capped by sialyl 6-sulfo Lex and the other by sia-
lyl 69-sulfo Lex. This mechanism would fit a model of selec-
tin binding proposed by Varki (1994), in which a specific
cluster of adjacent O-linked chains comprises the full
recognition determinant. Alternatively, individual chains
containing both modifications may underlie the synergistic
effect. In this regard, it should be noted that most of the
sulfated chains within GlyCAM-1 contain two or more sul-
fates, although the structure of these chains has not been
solved (Hemmerich et al., 1995). It is not yet clear whether
sialyl 69,6-disulfo Lex (Table I) exists as a capping group
on these multisulfated chains or whether there are ex-
tended chains containing sulfates on internal Gal or
GlcNAc residues. Additional analysis of natural ligands
will be required to resolve these important structural ques-
tions.
L-selectin normally functions in tethering and rolling of
lymphocytes on HEVs under conditions of blood flow
(Warnock et al., 1998). Future experiments must deter-
mine the impact of the two sulfation modifications on the
kinetic parameters of L-selectin binding to ligands, as
these parameters are the key determinants of the dynamic
interactions of lymphocytes with HEVs (Alon et al., 1997).
We are currently addressing these issues using a parallel
plate flow chamber to recapitulate physiological flow dy-
namics within blood vessels (Lawrence et al., 1995).
On the basis of its activities and highly restricted expres-
sion pattern, HEC-GlcNAc6ST is likely to be specifically
involved in the biosynthesis of the sialyl 6-sulfo Lex
epitope and related structures within L-selectin ligands.
Ultimately, it may be necessary to inactivate the gene in
mice by gene knockout to define the biological roles of
this enzyme. Experiments of this type were required to
demonstrate the critical role for FTVII in the generation
of selectin ligands, including the HEV ligands for L-selec-
tin (Maly et al., 1996). We cannot rule out the possible
involvement of another recently cloned GlcNAc-6-sul-
fotransferase identified in mice and humans (Uchimura et al.,
1998a,b) in ligand biosynthesis. As revealed by in situ hy-
bridization, transcripts encoding the latter enzyme were
present in HECs of mouse lymph nodes, although the
overall tissue expression pattern was extremely broad in
both species, suggesting other functions as well. In this re-
gard, it should be noted that 6-sulfated GlcNAc residues
are present in the GAG chains of keratan sulfate and a va-
riety of glycoproteins, including the N-linked oligosaccha-
rides of thyroglobulin (Kamerling et al., 1988), gp120 of
HIV (Shilatifard et al., 1993), and porcine zona pellucida
(Noguchi and Nakano, 1992). Furthermore, the GlcNAc-
6-sulfate motif in the context of the core-2 structure has
been identified in respiratory mucins from cystic fibrosis
patients (Lo-Guidice et al., 1994), and a GlcNAc-6-sul-
fotransferase activity, which can act on mucins, has been
detected in human respiratory mucosa (Degroote et al.,
1997).
With respect to the sialyl 69-sulfo Lex epitope, our data
on the acceptor specificity and expression pattern of
KSGal6ST are consistent with a possible role for this en-
zyme in the generation of the epitope within HECs. How-
ever, this enzyme (Fukuta et al., 1997), like the GlcNAc-
6-sulfotransferase described by Uchimura and colleagues
(1998a,b), is broadly distributed, being expressed in all of
the major organs. In analogy with HEC-GlcNAc6ST de-
scribed in the present study, one might predict the exist-
ence of an HEC-specific, or more highly restricted, Gal-
6-sulfotransferase that sulfates L-selectin ligands in vivo.
L-selectin–dependent leukocyte trafficking into lym-
phoid organs and inflammatory sites is likely to be subject
to complex regulation, which may be affected at the level
of L-selectin ligand biosynthesis through the availability of
protein scaffolds or by posttranslational modification.
Given the dramatic sulfate dependency of the interaction
between L-selectin and its ligands, and the high [35S]sul-
fate incorporation seen in HEVs and HEV-like vessels
(Girard and Springer, 1995a), it is tempting to speculate
that regulation of the expression or activity of one or both
of the relevant sulfotransferases represents critical control
points for this process. It is further plausible that the dif-
ferential expression of the sulfotransferases may contrib-
ute to the apparent variation in the posttranslational modi-
fications of L-selectin ligands in different lymphoid organs
(Berg et al., 1998; Mitsuoka et al., 1998). The expression of
KSGal6ST and HEC-GlcNAc6ST, as well as other candi-
date sulfotransferases, should also be examined in HEV-
like vessels that are induced at sites of chronic inflamma-
tion (Michie et al., 1993; Girard and Springer, 1995a;
Onrust et al., 1996). Endothelial ligands for L-selectin are
also inducible on flat-walled vessels in vivo, although the
biochemical nature of these ligands is poorly understood
(Ley and Tedder, 1995). In vitro models of endothelial ac-
tivation suggest that sulfation is required for the activity of
these ligands (Giuffrè et al., 1997; Zakrzewicz et al., 1997;
Tu et al., 1999). Endothelial sulfotransferases that are
implicated in inflammatory leukocyte trafficking would
clearly assume importance as potential targets for antiin-
flammatory therapeutics.
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